logo
Introduction: Risk management in asthma and allergic diseases
Late-phase inflammation: Influence on morbidity
Changing concepts of allergic disease: The attempt to keep up with real changes in lifestyles
Clinical comparison of histamine H1-receptor antagonist drugs
Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: Strategies and progress
Chronic urticaria: Pathophysiology and treatment approaches
Risk management in allergen immunotherapy
Legal issues in allergy and clinical immunology